Christie Thomas
Biographic Data
| ID | 7181024 |
|---|---|
| NAME | Christie Thomas |
| GIVEN NAMES | Christie |
| FAMILY NAME | Thomas |
| SIGNATURE | THOMAS C |
| AFFILIATIONS | Project Director, UCLA Integrated Substance Abuse Programs, Los Angeles, CA |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2014 |
| H-INDEX | 0 |
Patient Perspectives on Buprenorphine/Naloxone
This study examines the barriers and facilitators of retention among patients receiving buprenorphine/naloxone at eight community-based opioid treatment programs across the United States. Participants (n = 105) were recruited up to three and a half years after having participated in a randomized clinical trial comparing the effect of buprenorphine/naloxone and methadone on liver function. Semi-structured interviews were conducted with 67 patients…
Association of Race and Ethnicity With Withdrawal Symptoms, Attrition, Opioid Use, and Side-Effects During Buprenorphine Therapy
Some studies report differences in opioid withdrawal between racial/ethnic groups. However, it is not known if these differences are reflected in differential treatment response. Data from National Institute on Drug Abuse (NIDA) Clinical Trials Network-003 were used to examine racial/ethnic differences before and during stabilization with buprenorphine. At induction, non-Hispanic Caucasians had higher objective and subjective withdrawal scores an…
No prominent works on this page.
Association of Race and Ethnicity With Withdrawal Symptoms, Attrition, Opioid Use, and Side-Effects During Buprenorphine Therapy
Some studies report differences in opioid withdrawal between racial/ethnic groups. However, it is not known if these differences are reflected in differential treatment response. Data from National Institute on Drug Abuse (NIDA) Clinical Trials Network-003 were used to examine racial/ethnic differences before and during stabilization with buprenorphine. At induction, non-Hispanic Caucasians had higher objective and subjective withdrawal scores an…
Patient Perspectives on Buprenorphine/Naloxone
This study examines the barriers and facilitators of retention among patients receiving buprenorphine/naloxone at eight community-based opioid treatment programs across the United States. Participants (n = 105) were recruited up to three and a half years after having participated in a randomized clinical trial comparing the effect of buprenorphine/naloxone and methadone on liver function. Semi-structured interviews were conducted with 67 patients…
Buprenorphine (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Opioid (2 works) · Opioid use disorder (2 works) · Opioid Use Disorder Treatment (2 works) · Psychiatry (2 works) · Substance Abuse Treatment and Outcomes (2 works) · Addiction (1 works) · African american (1 works)